Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 4 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Recs

0
Player Avatar wombataholic (23.25) Submitted: 12/10/2010 4:34:33 PM : Underperform Start Price: $39.12 RDY Score: +28.29

Grossly overpriced.

Featured Broker Partners


Advertisement